News &
Media
Latest News

Aussie advanced manufacturing
On the 15th of April Phenomics Australia CEO, Dr. Michael Dobbie, joined other NCRIS capability representatives to celebrate with Minister Alan Tudge the launch of Australia’s

Phenomics Australia attended Science Meets Parliament 2021
Phenomics Australia attended the Science Meets Parliament 2021 event, hold virtually from 2 March to 1 April, as a Science and Technology Australia (STA) member. Science

Therapeutic Three for Harlequin Ichthyosis
A study on topical Aminosalicylic Acid as a treatment for harlequin ichthyosis, a severe genetic disorder of ABCA12 gene that mainly affects the skin. Read more

Therapeutic Target SERINC1 (Serine Incorporator 1)
A study on Serinc1, a carrier protein that facilitates lipid synthesis that may influence immune cell functions and result in autoimmune diseases. Read more here.

Phage PEV20 Dry-powder Formulation
An alternative to antibiotic treatment with minimal side effects for lung infection caused by multidrug-resistant (MDR) strain P. aeruginosa. Read more here.

Celebrating Women in Science February 11
Phenomics Australia celebrated the International Day of Women and Girls in Science on the 11th of February shining a spotlight on Phenomics Australia’s amazing women whose
Contribute to our news
Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.